Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 12:11 PM
Ignite Modification Date: 2025-12-25 @ 12:00 PM
NCT ID: NCT01822561
Description: None
Frequency Threshold: 5
Time Frame: 3 months. Patients were followed for a minimum of 3 months after treatment was initiated.
Study: NCT01822561
Study Brief: Eplerenone for Central Serous Chorioretinopathy
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Eplerenone Group All patients had central serous chorioretinopathy and were treated with 50mg oral eplerenone once daily 0 None 0 15 2 15 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Shortness of breath SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders None View
Palpitations SYSTEMATIC_ASSESSMENT Cardiac disorders None View